Screener
Arcutis Biotherapeutics, Inc. ARQT Business Segments — Selling, general, and administrative
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| ARQ-234 program costs | 1,302 | 845 | 12,305 | 2,034 |
| Other program costs | 102 | 1,193 | 197 | 2,375 |
| Research and development compensation and personnel-related expenses | 11,366 | 9,779 | 22,411 | 19,417 |
| Selling, general and administrative expenses | 82,008 | 69,033 | 155,962 | 132,917 |
| Other segment expenses(1) | 6,295 | 5,509 | 12,156 | 12,694 |
| Total operating expenses | 113,432 | 96,115 | 227,919 | 186,490 |
| Operating income (loss) | 16,429 | (14,611) | 7,340 | (39,140) |
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — selling, general, and administrative of $82.01M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative increased by 18.8% year-over-year, from $69.03M to $82.01M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative has grown at a 31.0% compound annual growth rate (CAGR), from $121.76M to $274.03M.
- What does business segments — selling, general, and administrative mean?
- Encompasses the overhead costs associated with the segment's commercial operations, including marketing, sales force support, and general administrative functions. It represents the operational investment required to scale market presence and support product commercialization.
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — selling, general, and administrative.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude